During Q3, Boston Properties (BXP) met FFO estimates and saw heavy activity, with its share prices being continually adjusted upwards by brokerage firms. An overall steady financial performance was reported, however, leasing occupation fell slightly. Investors like Raymond James & Associates and Sun Life Financial increased their stakes in the company. BXP successfully priced $850 million offering of senior unsecured notes and completed the sale of 45% interest in Kendall Square Life Sciences Property. The company underwent a rebranding to reflect "national, not singular city, focus". Although also facing some speculative elements, such as occupancy issues and tax proposal disputes, BXP continues to showcase market leadership with new development proposals. It also announced over 1.3 million square feet of leases and outperformed on second quarter earnings. The company’s stock hit a 52-week high of $83.92 indicating robust growth. Moving forward, BXP is strategizing on office plans for Reston Town Centre in Virginia, while partnering with the Mass Mobility Hub to support clean transport innovations.
Boston Properties BXP News Analytics from Fri, 29 Jun 2018 00:31:03 GMT to Thu, 31 Oct 2024 14:52:05 GMT -
Rating 6
- Innovation 0
- Information 8
- Rumor -3
